The outlook revision reflects Moody’s Investors Service’s expectation that Yavapai will continue to generate strong cash flow.
Moody’s also assigned a “Baa1” rating to Yavapai’s $43.8 million of series 2016 bonds.
The rating assignment is attributed to Yavapai’s track record of strong cash flow generation and solid market share as the only acute care hospital in its primary service area.
More articles on healthcare finance:
12 recent hospital outlook and credit rating actions
Hospitals’ best defense against denials is in the palm of your patient’s hand
Lawmakers to question NIH officials on funding for WHO cancer agency
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
